A citation-based method for searching scientific literature

Ton Fang, Goun Je, Peter Pacut, Kiandokht Keyhanian, Jeff Gao, Mehdi Ghasemi. Cells 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.
Michael D Weiss, Eric A Macklin, Zachary Simmons, Angela S Knox, David J Greenblatt, Nazem Atassi, Michael Graves, Nicholas Parziale, Johnny S Salameh, Colin Quinn,[...]. Neurology 2016
44
50

Intraspinal Transplantation of the Adipose Tissue-Derived Regenerative Cells in Amyotrophic Lateral Sclerosis in Accordance with the Current Experts' Recommendations: Choosing Optimal Monitoring Tools.
Magdalena Kuzma-Kozakiewicz, Andrzej Marchel, Anna Kaminska, Malgorzata Gawel, Jan Sznajder, Anna Figiel-Dabrowska, Arkadiusz Nowak, Edyta Maj, Natalia Ewa Krzesniak, Bartlomiej H Noszczyk,[...]. Stem Cells Int 2018
9
50

Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study.
Ryuji Kaji, Takashi Imai, Yasuo Iwasaki, Koichi Okamoto, Masanori Nakagawa, Yasuo Ohashi, Takao Takase, Takahisa Hanada, Hiroki Shimizu, Kunio Tashiro,[...]. J Neurol Neurosurg Psychiatry 2019
37
50

RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.
Yasushi Ito, Dimitry Ofengeim, Ayaz Najafov, Sudeshna Das, Shahram Saberi, Ying Li, Junichi Hitomi, Hong Zhu, Hongbo Chen, Lior Mayo,[...]. Science 2016
322
50

Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Ashley R Jones, William Sproviero, Aleksey Shatunov, Pamela J Shaw, P Nigel Leigh, Carolyn A Young, Christopher E Shaw, Gabriele Mora, Jessica Mandrioli,[...]. Neurology 2017
51
50

Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Alvaro Alonso, Giancarlo Logroscino, Miguel A Hernán. J Neurol Neurosurg Psychiatry 2010
74
50

Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.
Sabrina Paganoni, Chafic Karam, Nanette Joyce, Richard Bedlack, Gregory T Carter. NeuroRehabilitation 2015
32
50

AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALS.
Mark E Hester, Kevin D Foust, Rita W Kaspar, Brian K Kaspar. Curr Gene Ther 2009
42
50

Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis.
Christina M Lewis, Masatoshi Suzuki. Stem Cell Res Ther 2014
34
50

Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial.
Jesus S Mora, Angela Genge, Adriano Chio, Conrado J Estol, Delia Chaverri, Maria Hernández, Saúl Marín, Javier Mascias, Gabriel E Rodriguez, Monica Povedano,[...]. Amyotroph Lateral Scler Frontotemporal Degener 2020
82
50

Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype.
Frances Theunissen, Ryan S Anderton, Frank L Mastaglia, Loren L Flynn, Samantha J Winter, Ian James, Richard Bedlack, Stuart Hodgetts, Sue Fletcher, Steve D Wilton,[...]. Front Aging Neurosci 2021
22
50

Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis.
Simon Witzel, André Maier, Robert Steinbach, Julian Grosskreutz, Jan C Koch, Anastasia Sarikidi, Susanne Petri, René Günther, Joachim Wolf, Andreas Hermann,[...]. JAMA Neurol 2022
20
50

The "dying-back" phenomenon of motor neurons in ALS.
Michal Dadon-Nachum, Eldad Melamed, Daniel Offen. J Mol Neurosci 2011
244
50

Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS.
Nimeshan Geevasinga, Parvathi Menon, Karl Ng, Mehdi Van Den Bos, Karen Byth, Matthew C Kiernan, Steve Vucic. Amyotroph Lateral Scler Frontotemporal Degener 2016
45
50

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
Martine J Piccart-Gebhart, Marion Procter, Brian Leyland-Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, Jose Baselga, Richard Bell, Christian Jackisch,[...]. N Engl J Med 2005
50

Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Ryosuke Oki, Yuishin Izumi, Koji Fujita, Ryosuke Miyamoto, Hiroyuki Nodera, Yasutaka Sato, Satoshi Sakaguchi, Hiroshi Nokihara, Kazuaki Kanai, Taiji Tsunemi,[...]. JAMA Neurol 2022
5
50


Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.
Ammar Al-Chalabi, Andrea Calvo, Adriano Chio, Shuna Colville, Cathy M Ellis, Orla Hardiman, Mark Heverin, Robin S Howard, Mark H B Huisman, Noa Keren,[...]. Lancet Neurol 2014
210
50



Antibody-Based Therapeutic Interventions for Amyotrophic Lateral Sclerosis: A Systematic Literature Review.
Amélie Poulin-Brière, Edris Rezaei, Silvia Pozzi. Front Neurosci 2021
2
50

Potential Environmental Factors in Amyotrophic Lateral Sclerosis.
Björn Oskarsson, D Kevin Horton, Hiroshi Mitsumoto. Neurol Clin 2015
71
50

Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?
Nazem Atassi, Ettore Beghi, Miguel Blanquer, Nicholas M Boulis, Roberto Cantello, Claudia Caponnetto, Adriano Chiò, Stephen B Dunnett, Eva L Feldman, Angelo Vescovi,[...]. Cytotherapy 2016
17
50

Nonmotor Symptoms in Amyotrophic Lateral Sclerosis: A Systematic Review.
Ton Fang, Felix Jozsa, Ammar Al-Chalabi. Int Rev Neurobiol 2017
23
50

Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
Lorelei Stoica, Sophia H Todeasa, Gabriela Toro Cabrera, Johnny S Salameh, Mai K ElMallah, Christian Mueller, Robert H Brown, Miguel Sena-Esteves. Ann Neurol 2016
67
50

Ataxin-2 gene: a powerful modulator of neurological disorders.
Jose Miguel Laffita-Mesa, Martin Paucar, Per Svenningsson. Curr Opin Neurol 2021
4
50

Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis.
R Del Bo, C Tiloca, V Pensato, L Corrado, A Ratti, N Ticozzi, S Corti, B Castellotti, L Mazzini, G Sorarù,[...]. J Neurol Neurosurg Psychiatry 2011
71
50


The genetic architecture of ALS.
Aleksey Shatunov, Ammar Al-Chalabi. Neurobiol Dis 2021
27
50

Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.
Lindsey R Fischer, Deborah G Culver, Philip Tennant, Albert A Davis, Minsheng Wang, Amilcar Castellano-Sanchez, Jaffar Khan, Meraida A Polak, Jonathan D Glass. Exp Neurol 2004
948
50


Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials.
Jonathan D Glass, Vicki S Hertzberg, Nicholas M Boulis, Jonathan Riley, Thais Federici, Meraida Polak, Jane Bordeau, Christina Fournier, Karl Johe, Tom Hazel,[...]. Neurology 2016
88
50



Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.
Kevin D Foust, Desirée L Salazar, Shibi Likhite, Laura Ferraiuolo, Dara Ditsworth, Hristelina Ilieva, Kathrin Meyer, Leah Schmelzer, Lyndsey Braun, Don W Cleveland,[...]. Mol Ther 2013
141
50

Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
Sabrina Paganoni, Eric A Macklin, Suzanne Hendrix, James D Berry, Michael A Elliott, Samuel Maiser, Chafic Karam, James B Caress, Margaret A Owegi, Adam Quick,[...]. N Engl J Med 2020
115
50

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.
Koji Abe, Yasuto Itoyama, Gen Sobue, Shoji Tsuji, Masashi Aoki, Manabu Doyu, Chikuma Hamada, Kazuoki Kondo, Takatomo Yoneoka, Makoto Akimoto,[...]. Amyotroph Lateral Scler Frontotemporal Degener 2014
195
50

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial.
Richard Smith, Erik Pioro, Kathleen Myers, Michael Sirdofsky, Kimberly Goslin, Gregg Meekins, Hong Yu, James Wymer, Merit Cudkowicz, Eric A Macklin,[...]. Neurotherapeutics 2017
46
50

The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis.
L Van Den Bosch, P Van Damme, E Bogaert, W Robberecht. Biochim Biophys Acta 2006
332
50


A proposal for new diagnostic criteria for ALS.
Jeremy M Shefner, Ammar Al-Chalabi, Mark R Baker, Li-Ying Cui, Mamede de Carvalho, Andrew Eisen, Julian Grosskreutz, Orla Hardiman, Robert Henderson, Jose Manuel Matamala,[...]. Clin Neurophysiol 2020
130
50

Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study.
S Zoccolella, E Beghi, G Palagano, A Fraddosio, V Guerra, V Samarelli, V Lepore, I L Simone, P Lamberti, L Serlenga,[...]. J Neurol Neurosurg Psychiatry 2008
109
50

ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair.
Joseph R Klim, Luis A Williams, Francesco Limone, Irune Guerra San Juan, Brandi N Davis-Dusenbery, Daniel A Mordes, Aaron Burberry, Michael J Steinbaugh, Kanchana K Gamage, Rory Kirchner,[...]. Nat Neurosci 2019
175
50

Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial.
Suma Babu, Baileigh G Hightower, James Chan, Nicole R Zürcher, Pia Kivisäkk, Chieh-En J Tseng, Danica L Sanders, Ashley Robichaud, Haruhiko Banno, Armineuza Evora,[...]. Neuroimage Clin 2021
10
50

Sodium phenylbutyrate in Huntington's disease: a dose-finding study.
Penelope Hogarth, Luca Lovrecic, Dimitri Krainc. Mov Disord 2007
65
50

Phase 2 study of sodium phenylbutyrate in ALS.
Merit E Cudkowicz, Patricia L Andres, Sally A Macdonald, Richard S Bedlack, Rabia Choudry, Robert H Brown, Hui Zhang, David A Schoenfeld, Jeremy Shefner, Samantha Matson,[...]. Amyotroph Lateral Scler 2009
108
50

Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects.
Hidetoshi Shimizu, Yukiko Nishimura, Youichi Shiide, Kaori Yoshida, Manabu Hirai, Munetomo Matsuda, Yoshinobu Nakamaru, Yuichiro Kato, Kazuoki Kondo. Clin Pharmacol Drug Dev 2021
4
50


UNC13A is a modifier of survival in amyotrophic lateral sclerosis.
Frank P Diekstra, Paul W J van Vught, Wouter van Rheenen, Max Koppers, R Jeroen Pasterkamp, Michael A van Es, Helenius J Schelhaas, Marianne de Visser, Wim Robberecht, Philip Van Damme,[...]. Neurobiol Aging 2012
75
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.